Electrophoresis Reagents Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Gels, Dyes, Buffers, and Other Products), By Technique (Gel Electrophoresis and Capillary Electrophoresis), By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Laboratories, and Other End Users), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.93 Billion
CAGR (2026-2031)	5.93%
Fastest Growing Segment	Laboratories
Largest Market	North America
Market Size (2031)	USD 4.14 Billion

Market Overview

The Global Electrophoresis Reagents Market will grow from USD 2.93 Billion in 2025 to USD 4.14 Billion by 2031 at a 5.93% CAGR. Electrophoresis reagents are specialized chemical substances, including gels, buffers, and stains, utilized to facilitate the separation of macromolecules such as DNA, RNA, and proteins based on physical properties during laboratory analysis. The market is primarily propelled by the escalating demand for personalized medicine and the surge in genomic research activities which require precise molecular separation for drug discovery and diagnostics. According to the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical industry invested €55 billion in research and development within Europe in 2024, creating a robust financial environment that directly supports the high-volume consumption of these essential laboratory consumables.

Despite these favorable growth conditions, the market faces a significant challenge regarding the increasing adoption of alternative analysis technologies. High-resolution techniques such as Next-Generation Sequencing and High-Performance Liquid Chromatography are becoming preferred for specific high-throughput applications, presenting a competitive threat that could limit the reliance on traditional electrophoresis workflows in advanced research settings.

Key Market Drivers

The rising prevalence of chronic and infectious diseases acts as a primary catalyst for the Global Electrophoresis Reagents Market, necessitating advanced diagnostic and research tools. Laboratories increasingly rely on electrophoresis for the precise separation of nucleic acids and proteins to identify biomarkers associated with complex conditions such as cancer and tuberculosis. For instance, according to the American Cancer Society, January 2025, in 'Cancer Facts & Figures 2025', it was projected that 2,041,910 new cancer cases would be diagnosed in the United States alone, driving the consumption of reagents for genomic profiling and proteomic analysis. Similarly, the burden of infectious diseases continues to spur market activity; according to the World Health Organization, November 2025, in the 'Global Tuberculosis Report 2025', an estimated 10.7 million people fell ill with tuberculosis worldwide in the preceding year, underscoring the critical need for robust diagnostic workflows utilizing these essential consumables.

Concurrently, increasing R&D expenditure in pharmaceutical and biotechnology sectors is significantly bolstering market expansion. As drug developers intensify their search for novel therapeutics, the utilization of electrophoresis for quality control, drug characterization, and purity analysis has surged. This financial commitment is evident in major industry players; according to Novartis, January 2025, in the 'Annual Report 2024', the company allocated USD 9.3 billion to core research and development activities from continuing operations. Such substantial investment directly translates into sustained procurement of gels, buffers, and stains, ensuring that electrophoresis remains a fundamental technique in the drug discovery pipeline despite the emergence of alternative technologies.

Download Free Sample Report

Key Market Challenges

The increasing adoption of alternative analysis technologies, particularly Next-Generation Sequencing (NGS) and High-Performance Liquid Chromatography (HPLC), poses a direct barrier to the expansion of the Global Electrophoresis Reagents Market. As pharmaceutical companies and research laboratories prioritize these advanced methods for their superior throughput and genomic precision, there is a corresponding reduction in the reliance on traditional electrophoresis workflows. This technological substitution inevitably leads to a decreased procurement volume of essential consumables, such as gels and buffers, particularly in high-end applications where traditional separation methods are now considered less efficient or insufficiently granular.

This market contraction is driven by the industry's aggressive pivot toward precision therapies that necessitate the use of these sophisticated diagnostic platforms over standard techniques. According to the Personalized Medicine Coalition, in 2025, personalized medicines represented approximately 38 percent of all new therapeutic molecular entities approved by the FDA during the previous year. This substantial prioritization of complex, data-intensive treatment modalities incentivizes research centers to allocate larger portions of their budgets to NGS infrastructure rather than standard electrophoresis setups, thereby constraining the revenue growth potential for traditional reagent suppliers.

Key Market Trends

The shift toward automated electrophoresis workflows is fundamentally restructuring the market as laboratories prioritize reproducibility and throughput over traditional manual methods. While manual slab gels remain common in basic research, there is a marked transition toward automated capillary systems, particularly in clinical and quality control environments where data integrity and workflow efficiency are paramount. This divergence is evident in recent financial performance; according to Bio-Rad Laboratories, February 2025, in the 'Fourth-Quarter and Full-Year 2024 Financial Results', sales in the Clinical Diagnostics segment, which heavily utilizes automated screening, rose 3.7 percent to USD 1.5 billion, whereas the Life Science segment, largely dependent on traditional research workflows, declined by 12.6 percent. This contrast underscores a broader industry consolidation around automated platforms that minimize human error and maximize processing speed, allowing electrophoresis to remain competitive against alternative technologies.

Concurrently, the emergence of eco-friendly and sustainable reagents is becoming a critical differentiator in procurement decisions as institutions strive to reduce their environmental footprint. Stakeholders are increasingly demanding products that minimize hazardous waste and energy consumption, prompting manufacturers to reformulate buffers and obtain third-party sustainability validations for their production facilities. This commitment to green supply chains is accelerating; according to Thermo Fisher Scientific, September 2025, in the '2024 Corporate Social Responsibility Data Summary', the company significantly expanded its sustainability initiatives by adding 24 My Green Lab certifications during the year, bringing its total to 51 certified facilities. This trend drives the development of non-toxic stains and biodegradable gels, ensuring that electrophoresis remains a viable technique within the constraints of modern corporate social responsibility mandates.

Segmental Insights

The Laboratories segment represents the fastest-growing category within the Global Electrophoresis Reagents Market, driven primarily by the escalating prevalence of genetic and chronic diseases. This rise necessitates frequent DNA and protein analysis for early diagnosis and the development of personalized medicine. Furthermore, substantial research grants from organizations such as the National Institutes of Health (NIH) are enabling academic and clinical laboratories to expand their genomic capabilities. The increasing demand for high-quality, validated reagents to meet stringent compliance standards set by the U.S. Food and Drug Administration (FDA) further accelerates consumption in this sector.

Regional Insights

North America maintains a dominant position in the global electrophoresis reagents market due to an established healthcare infrastructure and substantial investment in life sciences research. The region benefits from the strong presence of major pharmaceutical and biotechnology companies that utilize these reagents for drug discovery and genomic analysis. Additionally, robust funding from institutions such as the National Institutes of Health supports extensive academic and clinical studies. A structured regulatory environment, overseen by the U.S. Food and Drug Administration, further stabilizes the market by streamlining the approval process for new medical technologies.

Recent Developments

• In September 2025, SCIEX, a global leader in life science analytical technologies, launched a new native fluorescence detection capability for its BioPhase 8800 system. This advancement was introduced at the CE Pharm symposium and was designed to enhance protein-based capillary electrophoresis assays, such as CE-SDS and cIEF, which are critical for characterizing biopharmaceuticals. The new detection method allows for the analysis of proteins using their naturally existing aromatic amino acids, thereby eliminating the need for complex dye labeling processes. This innovation aims to simplify sample preparation, reduce background noise, and significantly improve sensitivity for identifying low-abundant impurities in drug development workflows.
• In July 2024, Bio-Rad Laboratories announced the launch of the ChemiDoc Go Imaging System, a compact benchtop instrument designed for rapid and reliable gel and western blot imaging. This new system utilizes complementary metal oxide semiconductor (CMOS) digital imaging technology to deliver high sensitivity and resolution, comparable to larger instruments. The imager supports various detection methods, including chemiluminescence and fluorescence using StarBright Dyes, and is compatible with the company's cloud-based platform for enhanced data accessibility. This launch expands the company's portfolio of solutions for electrophoresis and protein quantification, offering researchers versatile tools for nucleic acid and protein analysis in life science laboratories.
• In April 2024, Sebia announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CAPILLARYS 3 DBS devices. This automated capillary electrophoresis system is specifically intended for the qualitative screening of hemoglobin disorders, such as sickle cell disease, in newborns using dried blood spots collected on filter paper. The clearance allows clinical laboratories to utilize this high-throughput platform to detect normal and abnormal hemoglobin variants with improved operational efficiency and full traceability. This regulatory milestone strengthens the company's position in the global diagnostics market by providing an innovative solution for hemoglobinopathy testing in infant populations.
• In January 2024, Agilent Technologies announced the release of the ProteoAnalyzer system, an automated parallel capillary electrophoresis platform designed to simplify the analysis of complex protein mixtures. Unveiled at the 23rd Annual PepTalk Conference, this new system addresses the growing demand for efficient protein quality control workflows in the pharmaceutical, biotechnology, and academic sectors. The platform offers rapid, high-resolution separation with minimal sample consumption, making it particularly suitable for analyzing monoclonal antibodies and other therapeutic proteins. By automating the separation and data processing steps, the system aims to streamline analytical workflows and improve the reliability of protein characterization in biopharmaceutical research and development.

Key Market Players

• Agilent Technologies, Inc.
• BioAtla, Inc.
• Bio-Rad Laboratories, Inc.
• Lonza Group Ltd.
• Merck KGaA
• Qiagen NV
• Takara Bio USA, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Hoefer Inc.

By Product	By Technique	By End User	By Region
Gels Dyes Buffers Other Products	Gel Electrophoresis and Capillary Electrophoresis	Academic and Research Institutions Pharmaceutical and Biotechnology Companies Laboratories Other End Users	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Electrophoresis Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Electrophoresis Reagents Market, By Product:

• Gels
• Dyes
• Buffers
• Other Products

• Electrophoresis Reagents Market, By Technique:

• Gel Electrophoresis and Capillary Electrophoresis

• Electrophoresis Reagents Market, By End User:

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Laboratories
• Other End Users

• Electrophoresis Reagents Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE